Healthy Ageing: a Feasibility Study to Evaluate Digitally-enabled Ways to Support Healthy Ageing

Summary

The goal of this clinical trial is to learn if it is feasibility to conduct a trial of two digitally-enabled interventions that support older adults to adopt healthy behaviours. It will also learn about the safety of this digital intervention. The main questions it aims to answer are

* How acceptable and feasible are the trial, intervention and control groups in assessing outcomes
* What is the estimated effect of the interventions? Researchers will compare Smart devices with a bespoke 'Healthy Habits' application and three healthy habit coaching and data feedback modules, to a group with smart devices and standard off-the-shelf feedback application, to a control group that will receive an education leaflet to adopt healthy behaviours.

Participants will:

* Use sensors and the 'Healthy Habits' application for 3 months followed by standard application for 3 months, or sensors and standard application for 6 months, or control
* Either home visit or in-centre visit once every 3 months for assessments and online health questionnaires
* Complete daily diary of any healthcare use

Conditions

• Frailty
• Older Adults (65 Years and Older)
• Digital Health Intervention
• Feasibility Studies

Interventions

COMBINATION_PRODUCT

Smart devices with Personalised data feedback and habit coaching

Smart devices (smartwatch and sleep mat) with a bespoke 'Healthy Habits' application with three healthy habit coaching and data feedback modules, focused on active minutes, steps and sedentary time, viewable on a tablet.

DEVICE

Smart devices with data feedback

Smart devices (smartwatch and sleep mat) with a standard off-the-shelf data feedback application ("WithingsTM App") providing generalised data feedback from the participant's smartwatch and sleep mat, viewable on a tablet for 6 months.

OTHER

Control

Standard care where they will be signposted to National Health Service (NHS) guidance on Healthy Ageing for older adults.

Sponsors & Collaborators

• Imperial College London

  lead OTHER

Principal Investigators

• Leila Shepherd, MEng, PhD · Imperial College London

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

65 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2025-07-28

Primary Completion

2026-03-26

Completion

2026-04-30

Countries

• United Kingdom

Study Locations